Definium Therapeutics, Inc. (NASDAQ:DFTX – Get Free Report) insider Mark Sullivan sold 14,051 shares of Definium Therapeutics stock in a transaction on Friday, September 25th. The shares were sold at an average price of $36.57, for a total value of $513,845.07. Following the transaction, the insider owned 494,228 shares in the company, valued at approximately […]

Definium Therapeutics, Inc. (NASDAQ:DFTX – Get Free Report) insider Matthew Wiley sold 3,097 shares of the business’s stock in a transaction dated Friday, September 25th. The stock was sold at an average price of $36.57, for a total transaction of $113,257.29. Following the sale, the insider directly owned 359,036 shares in the company, valued at […]

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) CFO Christopher Sullivan sold 12,394 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $16.33, for a total value of $202,394.02. Following the transaction, the chief financial officer directly owned 39,900 shares in the company, valued […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) EVP Peter Heerma sold 102,190 shares of the firm’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $62.26, for a total value of $6,362,349.40. Following the sale, the executive vice president directly owned 117,066 shares in the company, […]